Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neurofibroma × CNS × Clear all

Phase

Phase 2 9 Phase NA 5 Phase 1 4 Phase EARLY_PHASE1 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 248 Brain Neoplasms 159 Glioma 124 Central Nervous System Neoplasms 80 Gliosarcoma 72 Astrocytoma 66 Neuroblastoma 56 Oligodendroglioma 38 Breast Neoplasms 38 Neoplasms 36 Recurrence 32 Carcinoma, Non-Small-Cell Lung 28 Melanoma 25 Ovarian Neoplasms 23 Medulloblastoma 23 Lymphoma 21 Diffuse Intrinsic Pontine Glioma 20 Sarcoma 19 Neoplasm Metastasis 17 Lung Neoplasms 17 Rhabdomyosarcoma 15 Osteosarcoma 15 Meningeal Carcinomatosis 15 Colorectal Neoplasms 15 Sarcoma, Ewing 13 Pancreatic Neoplasms 13 Meningioma 12 Esophageal Neoplasms 12 Ependymoma 12 Stomach Neoplasms 11

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01140360 2017-07-02

0908-09

Indiana University

Phase 1/2 Completed

21 enrolled 8 charts

Neurofibroma, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon ⚡